Table 4 Procedural outcomes, complications and mortality
Parameter | Overall (n = 140) | TS (n = 50) | TA (n = 90) | p-value |
|---|---|---|---|---|
Aortic regurgitation at the end of procedure | ||||
None (%) | 69 (51.9%) | 17 (35.4%) | 52 (61.2%) | 0.006 |
Mild (%) | 56 (42.1%) | 25 (52.1%) | 31 (36.5%) | 0.053 |
Moderate (%) | 8 (6%) | 6 (12.5%) | 2 (2.4%) | 0.025 |
Severe (%) | 0 (0%) | 0 (0%) | 0 (0%) | NS |
Valve malpositioning (migration) (%) | 1 (0.7%) | 1 (2.0%) | 0 (0%) | 0.363 |
Bail-out valve-in-valve (%) | 1 (0.7%) | 1 (2.0%) | 0 (0%) | 0.380 |
Post implantation balloon dilatation of implanted valve (%) | 18 (13.5%) | 11 (22.4%) | 7 (8.3%) | 0.034 |
Peri- and post procedural complications | 12 (8.6%) | 4 (8%) | 8 (8.9%) | 1.000 |
Permanent pacing post procedure (%) | 8 (5.8%) | 3 (6%) | 5 (5.7%) | 1.000 |
Vascular access site and access related complications (%) | 10 (7.1%) | 6 (12%) | 4 (4.6%) | 0.105 |
Acute Kidney Injury within 7 days of procedure (%) | 16 (12.1%) | 3 (6.3%) | 13 (15.5%) | 0.167 |
Length of hospital stay (days) (mean ± SD) | 10.2 ± 10.7 | 10.7 ± 11.6 | 9.92 ± 10.3 | 0.682 |
Median (IQR) | 6 (6) | 6 (6.25) | 7 (6) | |
In-hospital mortality (%) | 4 (8%) | 5 (5.6%) | 0.721 | |
30-day mortality (%) | 3 (6%) | 5 (5.6%) | 0.905 | |
1-year mortality (%) | 9 (18%) | 14 (15.6%) | 0.704 | |
3-year mortality (%) | 16 (32%) | 24 (26.7%) | 0.302 | |
Follow-up time (days) (mean ± SD) | 680 ± 470 | 1006 ± 686 | 0.003 |